Advertisement

Cardiorenal Syndrome in Heart Failure Patients: ICU Management

  • Andrew Kowalski
  • Jonathan D. RichEmail author
Chapter
Part of the Difficult Decisions in Surgery: An Evidence-Based Approach book series (DDSURGERY)

Abstract

Cardiorenal syndrome is a condition manifest by the complex interplay and bidirectional injury that occurs to the cardiovascular and renal systems, respectively. Etiologies of the cardiorenal syndrome may be wide ranging but most commonly implicate impairment in the cardiovascular system leading to a vicious cycle of worsening cardiac and renal function. Treatment and management principles of this condition are complicated, sometimes misunderstood, and fraught with empiricism and the need to extrapolate data from similar but sufficiently diverse conditions and studies to this syndrome. This chapter seeks to elucidate the definitions, mechanisms, and treatment approaches to the heart failure patient with the cardiorenal syndrome in the intensive care unit.

Keywords

Cardiorenal syndrome Management Intensive care Acute decompensated heart failure Renal failure Acute kidney injury Volume overload Ultrafiltration Diuretics Inotropes 

References

  1. 1.
    Cardio-renal connections in heart failure and cardiovascular disease. 2004. Accessed 27 Jul 2017, at https://www.nhlbi.nih.gov/research/reports/2004-cardiorenal-hf-hd.
  2. 2.
    Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation. 2010;121:2592–600.CrossRefGoogle Scholar
  3. 3.
    Ronco C, McCullough PA, Anker SD, et al. Cardiorenal syndromes: an executive summary from the consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol. 2010;165:54–67.CrossRefGoogle Scholar
  4. 4.
    Heywood JT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422–30.CrossRefGoogle Scholar
  5. 5.
    Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–47.CrossRefGoogle Scholar
  6. 6.
    Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.CrossRefGoogle Scholar
  7. 7.
    Logeart D, Tabet JY, Hittinger L, et al. Transient worsening of renal function during hospitalization for acute heart failure alters outcome. Int J Cardiol. 2008;127:228–32.CrossRefGoogle Scholar
  8. 8.
    Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987–96.CrossRefGoogle Scholar
  9. 9.
    Shchekochikhin D, Schrier RW, Lindenfeld J. Cardiorenal syndrome: pathophysiology and treatment. Curr Cardiol Rep. 2013;15:380.CrossRefGoogle Scholar
  10. 10.
    Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589–96.CrossRefGoogle Scholar
  11. 11.
    Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53:582–8.CrossRefGoogle Scholar
  12. 12.
    Ellison DH, Felker GM. Diuretic treatment in heart failure. N Engl J Med. 2017;377:1964–75.CrossRefGoogle Scholar
  13. 13.
    Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2004;(3):CD003178.Google Scholar
  14. 14.
    Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797–805.CrossRefGoogle Scholar
  15. 15.
    Peacock WF, Costanzo MR, De Marco T, et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009;113:12–9.CrossRefGoogle Scholar
  16. 16.
    Shah RV, McNulty S, O'Connor CM, Felker GM, Braunwald E, Givertz MM. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. Am Heart J. 2012;164:862–8.CrossRefGoogle Scholar
  17. 17.
    Palazzuoli A, Pellegrini M, Ruocco G, et al. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care. 2014;18:R134.CrossRefGoogle Scholar
  18. 18.
    Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. Am J Cardiol. 2010;105:1794–7.CrossRefGoogle Scholar
  19. 19.
    Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010;16:188–93.CrossRefGoogle Scholar
  20. 20.
    Alqahtani F, Koulouridis I, Susantitaphong P, Dahal K, Jaber BL. A meta-analysis of continuous vs intermittent infusion of loop diuretics in hospitalized patients. J Crit Care. 2014;29:10–7.CrossRefGoogle Scholar
  21. 21.
    Wu MY, Chang NC, Su CL, et al. Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials. J Crit Care. 2014;29:2–9.CrossRefGoogle Scholar
  22. 22.
    Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002;287:628–40.CrossRefGoogle Scholar
  23. 23.
    Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol. 2005;46:2043–6.CrossRefGoogle Scholar
  24. 24.
    Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675–83.CrossRefGoogle Scholar
  25. 25.
    Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367:2296–304.CrossRefGoogle Scholar
  26. 26.
    Marenzi G, Muratori M, Cosentino ER, et al. Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail. 2014;20:9–17.CrossRefGoogle Scholar
  27. 27.
    Costanzo MR, Negoianu D, Jaski BE, et al. Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC Heart Fail. 2016;4:95–105.CrossRefGoogle Scholar
  28. 28.
    Yancy CW, Jessup M, for the Writing Committee, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;128:e240–327.PubMedGoogle Scholar
  29. 29.
    Varriale P, Mossavi A. The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function? Clin Cardiol. 1997;20:627–30.CrossRefGoogle Scholar
  30. 30.
    Ungar A, Fumagalli S, Marini M, et al. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med. 2004;32:1125–9.CrossRefGoogle Scholar
  31. 31.
    Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the dopamine in acute decompensated heart failure (DAD-HF) trial. J Card Fail. 2010;16:922–30.CrossRefGoogle Scholar
  32. 32.
    Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013;310:2533–43.CrossRefGoogle Scholar
  33. 33.
    Adams KF, De Marco T, Berkowitz RL. Inotrope use and negative outcomes in treatment of acute heart failure in patients with preserved systolic function: data from the ADHERE database. Circulation. 2003;108(Suppl IV):695.Google Scholar
  34. 34.
    Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med. 2011;184:1114–24.CrossRefGoogle Scholar
  35. 35.
    Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:e391–479.PubMedGoogle Scholar
  36. 36.
    Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625–33.CrossRefGoogle Scholar
  37. 37.
    Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122:265–72.CrossRefGoogle Scholar
  38. 38.
    Ahmad T, Jackson K, Rao VS, et al. Worsening renal function in acute heart failure patients undergoing aggressive diuresis is not associated with tubular injury. Circulation. 2018;37:2016–28.CrossRefGoogle Scholar
  39. 39.
    Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012;163:589–94.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Medicine, Division of NephrologyNorthwestern University Feinberg School of MedicineChicagoUSA
  2. 2.Department of Medicine, Division of CardiologyNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations